乳房インプラント：市場洞察・競合環境・市場予測 (～2030年)

乳房インプラントの市場規模は、2023年の18億米ドルから、予測期間中はCAGR 7.00％で推移し、2030年には27億米ドルの規模に成長すると予測されています。

乳癌患者の増加、製品開発活動の拡大、乳房再建および美容手術の増加、多種多様な乳房インプラントのアベイラビリティなどの要因から同市場は大きな成長を経験しています。

乳房インプラント：市場力学

Globocan 2024によると、世界全体で229万6,840人が乳癌に罹患したと報告されています。さらに、同ソースによると、この内訳はアジアが98万5,817人、欧州が55万7,532人、アフリカが19万8,553人の乳癌患者であったと報告されています。乳房切除後に再建手術を希望する患者が多いことから、世界の乳癌罹患率の高さがインプラントを含む乳房再建オプションの需要を促進しています。

主要参入企業によるさまざまな製品開発活動も同市場をさらに押し上げると考えられています。

製品タイプ別では、生理食塩水乳房インプラントが2023年に大きな市場シェアを占めると予想されています。これは、生理食塩水乳房インプラントに関連する様々な機能によるものです。

生理食塩水インプラントは、一般的に体が副作用なしに生理食塩水を吸収することができるので、破裂の場合により安全であると考えられています。この安全性の利点は、厳しい規制基準が患者の安全を優先する市場では特に重要であり、より高い採用率に貢献しています。

さらに、生理食塩水インプラントは、挿入後に充填されるため、挿入のための切開が少なくて済み、傷跡の少ない低侵襲手術を求める患者にとって魅力的です。さらに、改良されたシェル技術や調整可能な容量オプションなど、生理食塩水インプラントの設計の進歩により、耐久性、審美的な結果、カスタマイズ性が向上し、患者と外科医の両方にとって魅力的な選択肢となっています。

当レポートでは、世界の乳房インプラントの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 乳房インプラント市場レポート：イントロダクション

• 調査範囲
• 市場の分類
• 市場の想定

第2章 乳房インプラント市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 乳房インプラント市場：主要要因分析

• 市場促進要因
  • 乳癌患者の増加
  • 製品開発活動の活発化
  • 乳房再建手術および美容整形手術の増加
  • 多種多様な乳房インプラントが利用可能
• 市場抑制要因と課題
  • 乳房インプラントに伴う潜在的なリスク
  • 豊胸手術に伴う高額な費用
• 市場機会
  • ロボット支援レーザー手術の人気
  • 3Dプリント乳房インプラントの開発

第6章 乳房インプラント市場：ポーターのファイブフォース分析

第7章 乳房インプラント市場の評価

• 製品タイプ別
  • シリコン乳房インプラント
  • 生理食塩水乳房インプラント
• 形状別
  • ラウンド
  • アナトミカル
• テクスチャ別
  • スムーズ
  • テクスチャ
• エンドユーザー別
  • 病院
  • 外来手術センター
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 乳房インプラント市場：企業・製品プロファイル

• Johnson & Johnson Services, Inc.
• HansBioMed
• AbbVie Inc.
• IDEAL IMPLANT INCORPORATED
• Sebbin
• GC Aesthetics
• POLYTECH Health & Aesthetics GmbH
• SurgiSil
• Silimed
• CEREPLAS
• Establishment Labs

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Breast Implants Market in Global (2021-2030)
• Table 3: Breast Implants Market in Global by Product Type (2021-2030)
• Table 4: Breast Implants Market in Global by Shape (2021-2030)
• Table 5: Breast Implants Market in Global by Texture (2021-2030)
• Table 6: Breast Implants Market in Global by End-User (2021-2030)
• Table 7: Breast Implants Market in Global by Geography (2021-2030)
• Table 8: Breast Implants Market in North America (2021-2030)
• Table 9: Breast Implants Market in the United States (2021-2030)
• Table 10: Breast Implants Market in Canada (2021-2030)
• Table 11: Breast Implants Market in Mexico (2021-2030)
• Table 12: Breast Implants Market in Europe (2021-2030)
• Table 13: Breast Implants Market in France (2021-2030)
• Table 14: Breast Implants Market in Germany (2021-2030)
• Table 15: Breast Implants Market in United Kingdom (2021-2030)
• Table 16: Breast Implants Market in Italy (2021-2030)
• Table 17: Breast Implants Market in Spain (2021-2030)
• Table 18: Breast Implants Market in the Rest of Europe (2021-2030)
• Table 19: Breast Implants Market in Asia-Pacific (2021-2030)
• Table 20: Breast Implants Market in China (2021-2030)
• Table 21: Breast Implants Market in Japan (2021-2030)
• Table 22: Breast Implants Market in India (2021-2030)
• Table 23: Breast Implants Market in Australia (2021-2030)
• Table 24: Breast Implants Market in South Korea (2021-2030)
• Table 25: Breast Implants Market in Rest of Asia-Pacific (2021-2030)
• Table 26: Breast Implants Market in the Rest of the World (2021-2030)
• Table 27: Breast Implants Market in the Middle East (2021-2030)
• Table 28: Breast Implants Market in Africa (2021-2030)
• Table 29: Breast Implants Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Breast Implants Market in Global (2021-2030)
• Figure 3: Breast Implants Market in Global by Product Type (2021-2030)
• Figure 4: Breast Implants Market in Global by Shape (2021-2030)
• Figure 5: Breast Implants Market in Global by Texture (2021-2030)
• Figure 6: Breast Implants Market in Global by End-User (2021-2030)
• Figure 7: Breast Implants Market in Global by Geography (2021-2030)
• Figure 8: Breast Implants Market in North America (2021-2030)
• Figure 9: Breast Implants Market in the United States (2021-2030)
• Figure 10: Breast Implants Market in Canada (2021-2030)
• Figure 11: Breast Implants Market in Mexico (2021-2030)
• Figure 12: Breast Implants Market in Europe (2021-2030)
• Figure 13: Breast Implants Market in France (2021-2030)
• Figure 14: Breast Implants Market in Germany (2021-2030)
• Figure 15: Breast Implants Market in United Kingdom (2021-2030)
• Figure 16: Breast Implants Market in Italy (2021-2030)
• Figure 17: Breast Implants Market in Spain (2021-2030)
• Figure 18: Breast Implants Market in the Rest of Europe (2021-2030)
• Figure 19: Breast Implants Market in Asia-Pacific (2021-2030)
• Figure 20: Breast Implants Market in China (2021-2030)
• Figure 21: Breast Implants Market in Japan (2021-2030)
• Figure 22: Breast Implants Market in India (2021-2030)
• Figure 23: Breast Implants Market in Australia (2021-2030)
• Figure 24: Breast Implants Market in South Korea (2021-2030)
• Figure 25: Breast Implants Market in Rest of Asia-Pacific (2021-2030)
• Figure 26: Breast Implants Market in the Rest of the World (2021-2030)
• Figure 27: Breast Implants Market in the Middle East (2021-2030)
• Figure 28: Breast Implants Market in Africa (2021-2030)
• Figure 29: Breast Implants Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Marker Opportunities
• Figure 33: PORTER'S Five Force Analysis

Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of breast cancer and rising product developmental activities across the globe

The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030. The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and the availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.

Breast Implants Market Dynamics:

According to Globocan 2024, it stated that globally 2,296,840 were affected by breast cancer. Furthermore, the same source stated that Asia accounted for 985,817 breast cancer cases, Europe accounted for 557,532 breast cancer cases, and Africa accounted for 198,553 breast cancer cases. The high global incidence of breast cancer is driving demand for breast reconstruction options, including implants, as many patients seek reconstructive surgery post-mastectomy. This trend is expanding the market for breast implants, supporting physical and emotional recovery for survivors.

Various product developmental activities by the key market players will further boost the market for the same. For instance, in September 2024, GC Aesthetics(R) (GCA), a leading medical technology company committed to advancing women's health through innovative aesthetic and reconstructive breast solutions, announced the launch of the YOUTHLY(TM) brand in China, featuring its latest breast implant innovations; PERLE(TM), Luna XT(TM), and the latest version of The Round Collection(TM), 100% filled.

Additionally, in August 2024, CollPlant and Stratasys announced the pre-clinical study for regenerative breast implants with 200cc commercial-sized regenerative implants printed on a Stratasys Origin 3D printer.

Hence, the interplay of all the above-mentioned factors is expected to drive the breast implant market during the given forecast period from 2024 to 2030.

However, the potential risks associated with breast implants, the high cost associated with breast augmentation procedures, and others may restrict the market growth for the breast implants market.

Breast Implants Market Segment Analysis:

Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the breast implants market, saline breast implants are anticipated to hold a significant market share in the year 2023. This is due to various features associated with saline breast implants.

Saline implants are generally considered safer in cases of rupture, as the body can absorb the saline solution without adverse effects. This safety advantage is particularly important in markets where stringent regulatory standards prioritize patient safety, contributing to higher adoption rates.

Additionally, saline implants require a smaller incision for insertion, as they are filled after placement, which appeals to patients seeking minimally invasive procedures with reduced scarring. Furthermore, advancements in saline implant design, such as improved shell technology and adjustable volume options, have enhanced their durability, aesthetic outcomes, and customization, making them an attractive option for both patients and surgeons.

Additionally, in May 2024, Bimini Health Tech assembled a comprehensive portfolio incorporating the Serene structured saline breast implant, an Acellular Dermal Matrix (ADM), and the Puregraft family of fat transfer products.

Therefore, the widespread uses and various advantages of saline breast implant that enhance performance and usability, solidifying a significant impact on the growth of the overall breast implants market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall breast implant market:

Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, acting as key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.

According to the American Society of Plastic Surgeons 2024, it stated that in 2022, there were about 304,181 breast augmentation procedures in the US. The same source further stated that about 157,740 breast reconstruction procedures happened in the year 2022. Thus, the growing number of breast cosmetic surgeries and reconstruction procedures is anticipated to surge the demand for breast implants in the region, thereby propelling the market for the same.

As per data from Globocan 2024, it stated that in the year 2022, 274,375 people in the US and 31,823 people in Canada were affected by breast cancer. The high incidence of breast cancer in the region is driving the demand for breast implants, as many patients seek reconstructive surgery post-treatment. This trend highlights a growing market for breast implants, with a focus on supporting patients' recovery and body confidence.

Various product developmental strategies by key players in the region play a major role in pushing forward the revenue shares of breast implants in the region. For example, in October 2021, AbbVie, a manufacturer of breast implants launched a breast cancer campaign to highlight reconstruction options among women. Moreover, product launches by key market players in the region is further expected to propel the growth of the North America breast implants market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the breast implants market during the forecast period from 2024 to 2030.

Breast Implants Market key players:

Some of the key market players operating in the breast implants market include Johnson & Johnson Services, Inc., Hans BioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.

Recent Developmental Activities in the Breast Implants Market:

• In September 2024, Establishment Labs announced the US Food and Drug Administration (FDA) approval for its Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants.
• In April 2024, GC Aesthetics, a leading designer, manufacturer, and distributor of breast implants and medical devices for the global aesthetics industry, announced the micro-textured anatomical breast implant LUNA XT. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR).
• In May 2021, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions launched its next generation of breast implants, PERLE(TM).
• In January 2021, Mentor Worldwide LLC, a part of the Johnson & Johnson Medical Devices Companies received the US Food and Drug Administration (FDA) approval for the MENTOR(R) MemoryGel BOOST(TM) Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

Key takeaways from the Breast Implants market report study

• Market size analysis for current breast implants market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the breast implants market
• Various opportunities available for the other competitors in the breast implants market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current breast implant market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for breast implant market growth in the coming future?

Target audience who can be benefited from this Breast Implants market report study

• Breast implant providers
• Research organizations and consulting companies
• Breast Implant related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in breast implants
• Various end-users who want to know more about the breast implant market and the latest developments in the breast implant market

Frequently Asked Questions for the Breast Implants Market:

1. What are breast implants?

• The breast implants are prostheses (artificial devices) that are surgically inserted in the breast to change the shape, size, and contour of a person's breast. These implants are generally used for restoring a natural breast appearance following a mastectomy, to correct congenital defects and deformities of the chest wall, or, cosmetically, to enhance the look of the breast through breast augmentation surgery.

2. What is the market for breast implants?

• The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030.

3. What are the drivers for the breast implants market?

• The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the breast implants market?

• Some of the major market players operating in the breast implants market include Johnson & Johnson Services, Inc., HansBioMed, AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.

5. Which region has the highest share in the breast implant market?

• Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, which are the major key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Breast Implants Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Breast Implants Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Breast Implants Market Key Factors Analysis

• 5.1. Breast Implants Market Drivers
  • 5.1.1. Increasing cases of breast cancer
  • 5.1.2. Rising product developmental activities
  • 5.1.3. Rise in breast reconstructive and cosmetic surgeries
  • 5.1.4. Availability of a wide variety of breast implants
• 5.2. Breast Implants Market Restraints and Challenges
  • 5.2.1. Potential risk associated with breast implants
  • 5.2.2. High cost associated with breast augmentation procedures
• 5.3. Breast Implants Market Opportunities
  • 5.3.1. Growing popularity of robot-assisted laser surgeries
  • 5.3.2. Development of 3D printed breast implants

6. Breast Implants Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Breast Implants Market Assessment

• 7.1. By Product Type
  • 7.1.1. Silicone Breast Implants
  • 7.1.2. Saline Breast Implants
• 7.2. By Shape
  • 7.2.1. Round
  • 7.2.2. Anatomical
• 7.3. By Texture
  • 7.3.1. Smooth
  • 7.3.2. Textured
• 7.4. By End-User
  • 7.4.1. Hospitals
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Breast Implants Market Size in USD million (2021-2030)
    • 7.5.1.2. Canada Breast Implants Market Size in USD million (2021-2030)
    • 7.5.1.3. Mexico Breast Implants Market Size in USD million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Breast Implants Market Size in USD million (2021-2030)
    • 7.5.2.2. Germany Breast Implants Market Size in USD million (2021-2030)
    • 7.5.2.3. United Kingdom Breast Implants Market Size in USD million (2021-2030)
    • 7.5.2.4. Italy Breast Implants market size in USD million (2021-2030)
    • 7.5.2.5. Spain Breast Implants Market Size in USD million (2021-2030)
    • 7.5.2.6. Rest of Europe Breast Implants Market Size in USD million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Breast Implants Market Size in USD million (2021-2030)
    • 7.5.3.2. Japan Breast Implants Market Size in USD million (2021-2030)
    • 7.5.3.3. India Breast Implants Market Size in USD million (2021-2030)
    • 7.5.3.4. Australia Breast Implants Market Size in USD million (2021-2030)
    • 7.5.3.5. South Korea Breast Implants Market Size in USD million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Breast Implants Market Size in USD million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Breast Implants Market Size in USD million (2021-2030)
    • 7.5.4.2. Africa Breast Implants Market Size in USD million (2021-2030)
    • 7.5.4.3. South America Breast Implants Market Size in USD million (2021-2030)

8. Breast Implants Market Company and Product Profiles

• 8.1. Johnson & Johnson Services, Inc.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. HansBioMed
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. AbbVie Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. IDEAL IMPLANT INCORPORATED
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Sebbin
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. GC Aesthetics
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. POLYTECH Health & Aesthetics GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. SurgiSil
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Silimed
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. CEREPLAS
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Establishment Labs
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us